Pocard M, Chevillard S, Villaudy J, Poupon M F, Dutrillaux B, Remvikos Y
UMR 147: Cytogénétique Moléculaire et Oncologie, Institut Curie 26, Paris, France.
Oncogene. 1996 Feb 15;12(4):875-82.
The LoVo colon carcinoma cell line that presents two wild type p53 alleles was used as the recipient for a series of transfections with p53 expression vectors coding for wild-type or three different mutants (143ala, 175his or 273his). The parental cell line as well as all clones that had rearranged the plasmid with consequent loss of p53 c-DNA were readily blocked at the G1/S boundary following 10 Gy of irradiation. For each mutation two clones with different levels of mutant protein expression were selected. Confirmation of the integration of the exogenous sequence was obtained by the expression of the mutant m-RNA, established by reverse transcription and DGGE or Southern blot. Flow cytometric measurements of 5-bromodeoxyuridine incorporation revealed a total G1/S block of the 143ala transfectants, similarly to the parental and control transfectant cells, but little or no cell cycle block for the 175his and 273his clones. Although it has been shown in vitro that all three mutations interfere with transcriptional activation by the wild-type protein, not only did we observe p53 protein induction and nuclear accumulation following irradiation, but WAF-1/CIP-1 m-RNA was increased in some of the clones for which the G1/S block was abolished. Our results show that mutant p53 proteins are to some extent submitted to the control of the cellular environment in cancer cells with wild type p53 alleles, but with an efficacy that depends on the mutation.
具有两个野生型p53等位基因的LoVo结肠癌细胞系被用作受体,用编码野生型或三种不同突变体(143ala、175his或273his)的p53表达载体进行一系列转染。亲代细胞系以及所有因质粒重排导致p53 cDNA丢失的克隆在接受10 Gy照射后很容易在G1/S边界处被阻断。对于每种突变,选择了两个具有不同水平突变蛋白表达的克隆。通过逆转录和DGGE或Southern印迹法确定的突变体mRNA的表达,证实了外源序列的整合。5-溴脱氧尿苷掺入的流式细胞术测量显示,143ala转染子与亲代和对照转染细胞一样,在G1/S期完全被阻断,但175his和273his克隆几乎没有或没有细胞周期阻断。尽管体外实验表明所有这三种突变都会干扰野生型蛋白的转录激活,但我们不仅观察到照射后p53蛋白的诱导和核积累,而且在一些G1/S阻断被消除的克隆中,WAF-1/CIP-1 mRNA增加。我们的结果表明,在具有野生型p53等位基因的癌细胞中,突变型p53蛋白在一定程度上受细胞环境的控制,但其效力取决于突变情况。